Skip to main content
Clinical Trials/PACTR201306000510382
PACTR201306000510382
Not yet recruiting
未知

Transient Neurologic symptoms following spinal lignocaine and bupivacaine for caesarean delivery in mulago hospital, a randomised trial.

Dr Aggrey Lubikire(self)0 sites180 target enrollmentFebruary 26, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Nervous System Diseases
Sponsor
Dr Aggrey Lubikire(self)
Enrollment
180
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 26, 2013
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Dr Aggrey Lubikire(self)

Eligibility Criteria

Inclusion Criteria

  • only ASA 1 and 2 and E , patients above 18 and provide informed consent to participate in the study will be enrolled.

Exclusion Criteria

  • Patients with previous neurologic deficits, periperal neuropathy like diabetes, previous back injuries.
  • Failed spinal :patients who receive spinal blockade with either Lignocaine or Bupivacaine, and the drug fails to take, then get general anaesthesia will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials